Skip to main content
SpringerLink
Log in

Psychopharmacological Aspects of Geriatric Medicine

  • Chapter
Aging and the Brain

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 3))

Abstract

Geriatric patients frequently develop psychiatric disorders, so frequently, in fact, that a new subspecialty of geriatric medicine has recently emerged which is becoming known as geropsychiatry. The psychiatric syndromes and symptoms observed in geriatric patients are not essentially different from those encountered in younger patients, but aging tends to develop certain “host qualities” in people which render them selectively more susceptible to certain stresses and more prone to certain pathological manifestations than to others. Because aging favors degenerative diseases, we see in geriatric patients a prevalence of psychopathology which is either the direct outcome of degenerative brain disease or reflects a functional reaction to it.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahmed, A. 1968. Thioridazine in the management of geriatric patients. J. Amer. Geriat. 16(8):945.

    CAS  Google Scholar 

  • Altschul, R. 1959. Einfluss von Cytochrome C auf Serum Cholesterin. Kreislaufforsch. 48:844.

    CAS  Google Scholar 

  • Asian, A. 1956. A new method for prophylaxis and treatment of aging with novocain-eutrophic and rejuvenating effects. Therapiewoche 7:14.

    Google Scholar 

  • Assessment in Cerebrovascular Insufficiency. An International Symposium on Various Methods of Assessing the Effects of Cyclandelate on Higher Cortical Function, Würzburg 1970. G. Stöker, R.A. Kuhn, P. Hall, G. Becker, E. van der Veen (eds.). Stuttgart:Georg Thieme Verlag, 1971.

    Google Scholar 

  • Bergener, von M. 1967. Behandlung psychiatrischer Krankheitszustände in Alter. Hippokrates 38:432.

    PubMed  CAS  Google Scholar 

  • Bogomolets, A.P. 1946. The Prolongation of Life. New York:Duell, Sloan & Pearce.

    Google Scholar 

  • Bower, H.M., and McDonald, C. 1966. A controlled trial of A.N.P. 235 (“Lucidrir”) in senile dementia. Med. J. Aust. 2(6):270.

    PubMed  CAS  Google Scholar 

  • Burke, G., and Halko, A. 1968. Quoted in editorial by W.C. Alvarez. Geriatrics 23:96.

    Google Scholar 

  • Chynoweth, R., and Foley, J. 1969. Pre-senile dementia responding to steroid therapy. Brit. J. Psychiat. 115:703.

    Article  PubMed  CAS  Google Scholar 

  • Deitrick, R.A. 1967. Pentylenetetrazol with nicotinic acid in the management of chronic brain syndrome. J. Amer. Geriat. 15:191.

    CAS  Google Scholar 

  • Espie, M.J. 1966. Pharmacologie de la centrophénoxine. Application au delirium tremens. Lyon Med. 215:935.

    Google Scholar 

  • Fünfgeld, E.W. 1970. Ergebnisse medikamentöser Therapie bei älteren Patienten mit cerebralorganischen Störungen. Nervenarzt 41:352.

    PubMed  Google Scholar 

  • Gerstenbrand, F.; Hoff, H.; and Prosenz, P. 1963. Therapeutische Erfahrungen mit Lucidril bei neuro-psychiatrischen Krankheitsbildern. (Therapeutic experiences with Lucidril in neuropsychiatric disease pictures.) Wien. Med. Wschr. 113(25–26):539.

    PubMed  CAS  Google Scholar 

  • Hall, P. and Harcup, M. 1969 suppl. A trial of lipotropic enzymes in atheromatous (“arteriosclerotic”) dementia. Angiology 20:287.

    Article  PubMed  CAS  Google Scholar 

  • Hedlund, S.; Köhler, V.; Nylin, G.P.; Olsson, R.; Regnström, O.; Rothström, E.; and Aström, K.E. 1964. Cerebral blood circulation in dementia. Acta Psychiat. Scand. 40:77.

    Article  PubMed  CAS  Google Scholar 

  • Hunter, J.D. 1960. Nicotinic acid therapy in patients with coronary disease. New Zeal MJ. 59:60. Kayatan, S. 1960. Atherosclerosis and betaglucuronidase. Lancet 2:667.

    Google Scholar 

  • Kety, S.S. 1956. Human cerebral blood flow oxygen consumption as related to aging. In The Neurologic and Psychiatric Aspects of the Disorders of Aging. Baltimore: Williams & Wilkins.

    Google Scholar 

  • Kral, V.A. 1958. Senescent memory decline and senile amnestic syndrome. Amer. J. Psychiat. 115:361.

    PubMed  CAS  Google Scholar 

  • LaBrecque, D.C., and Goldberg, R.I. 1967. A double blind study of pentylenetetrazol combined with niacin in senile patients. Curr. Ther. Res. 9:611.

    PubMed  CAS  Google Scholar 

  • Leckman, J.; Ananth, J.V.; Ban, T.A.; and Lehmann, H.E. 1971. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. J. Clin. Pharmacol. 11(4):301.

    CAS  Google Scholar 

  • Lehmann, H.E. 1959. Methods of evaluation of drug effects on the human central nervous system. In The Effect of Pharmacologic Agents on the Nervous System. Baltimore: Williams & Wilkins.

    Google Scholar 

  • Lehmann, H.E., and Ban, T.A. 1970. Pharmacological load tests as predictors of pharmacotherapeutic response in geriatric patients. In Psychopharmacology and the Individual Patient. J.R. Wittenborn, S.G. Goldberg, and P.R.A. May (eds.). New York: Raven Press.

    Google Scholar 

  • Lehmann, H.E.; Ban, T.A.; and Kral, V.A. 1968. Psychological tests: Practice effect in geriatric patients. Geriatrics 23:160.

    PubMed  CAS  Google Scholar 

  • Lehmann, H.E., and Knight, D.A. 1958. Psychophysiological testing with a new phrenotropic drug. In Trifluoperazine: Clinical and Pharmacological Aspects. H. Brill (ed.). Philadelphia:Lea & Febiger.

    Google Scholar 

  • Levy, S. 1963. Pharmacological treatment of aged patients in a state mental hospital. JAMA 153:1260.

    Article  Google Scholar 

  • Lifschitz, K., and Kline, N. 1963. Psychopharmacology of the aged. In Clinical Principles and Drugs in the Aging. J. Freeman (ed.). Springfield: Charles C Thomas.

    Google Scholar 

  • Müller, H. 1967. Drugs — EEG and the aged. Presented at a symposium on Psychoactive Drugs in the Aged. Quebec Psychopharmacological Research Association, Quebec, Canada.

    Google Scholar 

  • Niehans, P. 1952. Zur Geschichte der Zellular-Therapie, zugleich eine Richtigstellung. Hippokrates 27:219.

    Google Scholar 

  • Overall J.E., and Gorham D.R. Feb. 1971. Organicity versus old age in objective and projective test. performance. Psychometric Laboratory Reports No. 16. Dept. of Neurology and Psychiatry, Psychometric Laboratory. The University of Texas Medical Branch, Galveston, Texas.

    Google Scholar 

  • Schindler, Von R.; Steininger, E.; and Waitusch, A. 1968. Noverilbehandlung von psychiatrischen Alterpatienten. Wien. Med. Wschr. 118:368.

    PubMed  CAS  Google Scholar 

  • Silver, D.; Debow, S.L.; Lehmann, H.E.; Kral, V.A.; and Ban, T.A. Nov. 1967. The comparative effectiveness of psychoactive drugs in hospitalized geriatric patients. Presented at the Quebec Psychopharmacological Research Association Meeting, Quebec, Canada.

    Google Scholar 

  • Stern, F.H. 1970. Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride. J. Amer. Geriat. 18(6):507.

    CAS  Google Scholar 

  • Stöker, G. 1971. Cerebral functions and cerebral blood flow. In Assessment in Cerebrovascular Insufficiency by G. Stöker, R.A. Kuhn, P. Hall, G. Becker, and E. van der Veen. Stuttgart: Georg Thieme Verlag.

    Google Scholar 

  • Wietec, H.F. 1966. Zum Einfluss von Centrophenoxin auf das Alterspigment Lipofuscin in Nervenzellen. (The influence of centrophenoxine on lipofuscin, the pigment of old age in nerve cells). Arzneimittel-Forschung 16(8): 1123.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Douglas Hospital, Verdun, Quebec, Canada

    H. E. Lehmann M.D.

Authors
  1. H. E. Lehmann M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gerontology Research Section, Texas Research Institute of Mental Sciences, Houston, Texas, USA

    Charles M. Gaitz (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1972 Plenum Press, New York

About this chapter

Cite this chapter

Lehmann, H.E. (1972). Psychopharmacological Aspects of Geriatric Medicine. In: Gaitz, C.M. (eds) Aging and the Brain. Advances in Behavioral Biology, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8503-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8503-5_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8505-9

  • Online ISBN: 978-1-4684-8503-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation